Cancer
How Big Pharma Tried to Gag This Remarkable Cancer Pioneer
Date: 23/06/11
Keywords: American Food and Drug Administration (FDA), Alternative medicine, Bone Cancer, Brain Cancer, Breast Cancer, Bowel Cancer, Cancer
Dr. Burzynski’s story begins back in the early 1970's when he discovered that people suffering with cancer lacked a certain peptide, in comparison to those who were cancer- free. This led him to develop a treatment known as antineoplastons — a gene-targeted therapy that uses a non- toxic mixture of peptides and derivatives of amino acids, known to act as molecular switches as well as genetic switches, turning on cancer suppressing genes, while simultaneously turning oncogenes (cancer genes) off!
Let’s say you’re a doctor (a biochemist, to be more precise) who dedicates almost your entire life to cancer research. Finally, you discover the genetic mechanism that could possibly cure most human cancers...
Now, you’d think the medical authorities would embrace you with open arms and immediately roll out the red carpet. After all, the world has been waiting for a cancer cure for goodness knows how long...
This, unfortunately was not the case when Dr. Stanislaw Burzynski, a polish-born physician from Houston, Texas, in the US, developed a non-toxic, gene targeted cancer medicine in the 1970s... In fact, his discovery was treated as a criminal offence!...
Dr. Burzynski’s story was recently highlighted in Nutrition and Healing — Dr. Jonathan Wright's monthly journal... and Dr. Wright knows all to well what it feels like to be hounded by the medical authorities
The results speak for themselves
Dr. Burzynski’s story begins back in the early 1970's when he discovered that people suffering with cancer lacked a certain peptide, in comparison to those who were cancer- free. This led him to develop a treatment known as antineoplastons — a gene-targeted therapy that uses a non- toxic mixture of peptides and derivatives of amino acids, known to act as molecular switches as well as genetic switches, turning on cancer suppressing genes, while simultaneously turning oncogenes (cancer genes) off!
Of course, there are other gene-targeting cancer drugs available today, but they only target a small number of specific cancer genes, whereas antineoplastons target a wide spectrum of cancer genes — about 100 of them at the same time! To put it plainly, antineoplastons are to cancer what a broad-spectrum antibiotic is to infectious disease...
The clinical trial data of conventional cancer therapies versus antineoplastons stacked against each other, shows exactly what the remarkable benefits of antineoplastons are.
Studies have shown that 5 out of 54 patients (9 per cent) treated with radiation or chemotherapy, were cancer-free at the end of treatment. In comparison to 5 of 20 patients treated (25 per cent) with antineoplastons being cancer-free at the end of treatment... Best yet, antineoplastons are completely non-toxic... definitely not a benefit of chemo or radiation therapy, which are both side effect ridden and in some cases even cause cancer!
Whilst in my eyes (and probably the thousands of cancer patients treated by Dr. Burzynski), the man deserves a medal for his dedication and commitment alone, the American Food and Drug Administration (FDA), Big Pharma, and the National Cancer Institute did not feel the same...
Silencing the truth
Despite treating thousands of patients successfully, Dr. Burzynski has suffered a tremendous onslaught from Big Pharma and the medical authorities. To start with, he had tried to get the FDA to review and approve antineoplastons since 1977, but to no avail.
In 1984, agents from the Texas board of medical examiners started to taunt Dr. Burzynski’s patients across the US, trying to convince them to file charges against him... even though Dr. Burzynski wasn’t breaking any laws by treating his patients with antineoplastons.
Finally, in 1988, having produced more evidence than was required to show that his treatment was effective and that no harm was coming to his patients from it, the Texas medical board charged him with breaking a law that didn't exist, claiming it was grounds for revoking his medical license.
In 1993, the case went to trial. By then, sixty of Dr. Burzynski's patients had filed a petition against the medical board requesting them to stop harassing their doctor — a petition that the board successfully eliminated from the trial by filing a motion to strike it from the record.
Once the judge in the initial trial ruled in favour of Dr. Burzynski, confirming that no laws had been broken, the Texas medical board filed charges against Dr. Burzynski with the Texas Supreme Court...
You can see where this is going... Eventually it came to light that the FDA had pressured the Texas medical board to revoke Dr. Burzynski's medical license... Now remember, no laws were broken and his treatment was proven safe and effective!
Why then this witches hunt?
Follow the money
The FDA and Big Pharma had realized that if Dr. Burzynski's groundbreaking discovery — which he owned the patent for — received a fair review, chemotherapy and radiation would no longer be the therapies of ‘choice’ (much as patients have a choice in these matters).
Not only that, but if antineoplastons were approved, billions of dollars of cancer research funds would get funnelled over to one single scientist who had exclusive patent rights... Clearly, Dr. Burzynski and his miracle cure was a massive threat to the entire profit-driven cancer industry... and you know what these guys do with a threat... They’ll do anything to make it go away...
There’s a lot more to Dr. Burzynski’s story, which is why I urge you to watch this video, which will tell you the story of the good doctor who eventually won the largest, and possibly the most elaborate and intriguing legal battle against the FDA in history.
Sources:
‘The Great Cancer Hoax: The Brilliant Cure the FDA Tried Their Best to Shut Down...’ published online 11.06.2011, articles.mercola.com
‘Deadly peril that may be hiding in your dishwasher’, published online 22.06.2011, express.co.uk
Click here to send to a friendShare thisPrinter friendly version
